In Kalundborg, population under 17,000, Novo Nordisk is making huge investments to increase production of its popular diabetes and weight-loss drugs, Ozempic and Wegovy.
source https://www.nytimes.com/2024/04/20/business/ozempic-denmark-novo-nordisk.html
0 Comments